Udenafil CAS 268203-93-6

Udenafil is the fourth in a class of drugs targeting the inhibition of the enzyme phosphodiesterase 5 (PDE5) for the treatment of erectile dysfunction. Inhibition of PDE5 results in the increase in endogenous cyclic guanosine monophosphate (cGMP) concentrations in the penile corpus cavernosum. cGMP induces smooth muscle cell relaxation and subsequent increased blood flow leading to a sustainable erection. Udenafil is a potent antagonist of human PDE5 with an IC₅₀ of 8.25nM and a comparable selectivity profile as sildenafil for the other PDEs. Unlike tadalafil, it does not inhibit PDE11, which has been implicated in myalgia and testicular toxicity. Furthermore, udenafil produced up to a 91% vaginal penetration success rate and up to a 67% intercourse completion rate compared to a 29% completion rate by placebo. Overall patient satisfaction, measured by a standard global assessment question, was 86% compared to only 26% in the placebo group. The most frequently recorded adverse events were mild-to-moderate facial flushing and headache.

Udenafil is an inhibitor of phosphodiesterase 5 (PDE5). In vivo, udenafil (1 and 5 mg/kg) increases lung cGMP levels, attenuates the development of compensatory right ventricular hypertrophy, and reduces pulmonary arterial wall thickening in a rat model of monocrotaline-induced pulmonary hypertension. It increases creatine clearance and decreases blood urea nitrogen (BUN) and serum malondialdehyde (MDA) levels in a rat model of renal ischemia-reperfusion injury. Udenafil (0.3 and 10 mg/kg) induces penile erections in conscious rabbits and in rabbits with acute spinal cord injury.

E tele a matou fale gaosi oloa maualuga ma le galulue faʻatasi, lea e mafai ona tuʻuina atu ia te oe oloa maualuga ma tau faʻatauvaʻa. Ma e mafai foi ona matou tuʻuina atu faʻaitiitiga mo faʻatauga tele.Ma matou te galulue faʻatasi ma le tele o kamupani faʻapolofesa felauaiga uta, e mafai ona tuʻuina atu oloa ma le saogalemu ma le sologa lelei i ou lima. Le taimi tu'uina atu e tusa ma le 3-20 aso talu ona fa'amaonia le totogiina.

Product Name:	Udenafil
Synonyms:	5-[2-propyloxy-5-(2-(1-Methylpyrrolidin-2-yl)ethylaMinosulphonyl)phenyl]-1-Methyl-3-propyl-6,7-dihydro-1H-pyrazolo(4,3-d)pyriMidin-7-one;5-[2-propyloxy-5-[2-(1-Methyl-2-pyrrolidinyl)ethylaMinosulfonyl]phenyl]-1-Methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyriMidine-7-one;Zydena;Udenafil(DA 8159,Zydena);BenzenesulfonaMide,3-(6,7-dihydro-1-Methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyriMidin-5-yl)-N-[2-(1-Methyl-2-pyrrolidinyl)ethyl]-4-propoxy-;Udenafil, DA 8159;CS-1353;Udenafil, >=98%
CAS:	268203-93-6
MF:	C25H36N6O4S
MW:	516.66
EINECS:	251-228-4
Product Categories:	Intermediates & Fine Chemicals;Pharmaceuticals
Mol File:	268203-93-6.mol

1. O oe o se falegaosimea po'o se kamupani fefa'ataua'iga?
O matou o se compnay tu'ufa'atasiga alamanuia ma fefa'ataua'iga, tu'uina atu le tasi-taofi service.OEM e mafai ona talia.

2. E te tuʻuina atu faʻataʻitaʻiga? E leai se totogi pe fa'aopoopo?
Fa'ata'ita'iga fua.E mana'omia ona totogi le tau o uta a le fa'ata'ita'iga i lou itu.

3. E i ai ni au tusi faamaonia e fesoʻotaʻi ma le pulea lelei?
ISO 9001: 2008 faʻamaonia e faʻamautinoa le lelei.

4. O le a le mea e tatau ona ou saunia e maua ai se upusii?
Pls taʻu mai ia i matou le ituaiga oloa e te manaʻomia, faʻatonuga tele, tuatusi ma manaoga faʻapitoa.O le upusii o le a faia mo lau faʻamatalaga i le taimi.

5. O le a le ituaiga auala totogi e te manaʻo ai? O a ituaiga tuutuuga e talia?
Taliaina Tu'uina atu: FOB,CFR,CIF,EXW;
Talia Totogi Tupe:USD;
Tulaga Totogi Talia: T / T, Western Union; Paypal, Fefa'ataua'iga Fa'amautinoa.
Gagana Gagana: Igilisi.